February 4, 2015
Wednesday’s RegMed rhythms: too many oversold stalwarts, a warning sign and it’s time to go UP
February 3, 2015
RegMed’s back and forth and that's going to go on for a while
February 3, 2015
Histogenics (HSGX) and CMO move on
February 2, 2015
RegMed’s message, it is what it is - get on with it
February 2, 2015
Histogenics (HSGX) new BOD member and Chair of Audit Committee
January 30, 2015
RegMed’s low volume and pricing swings keep hair-pulling uncertainty alive
January 30, 2015
Friday’s RegMed rhythm: a failure to impress
January 29, 2015
RegMed’s mood ring turns amber from gray, an involuntary volatility reaction to sector movement
January 28, 2015
RegMed’s risk and volatility is more spontaneous than just emerging
January 28, 2015
Wednesday’s RegMed rhythms: pops, drops and belly flops
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.